drugset / Trial / NCT03019081
Augmented Interoceptive Exposure Training in Anorexia Nervosa
Unknown
25 enrolled
Laureate Institute for Brain Research, Inc.
Brain & Behavior Research Foundation · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The researchers propose to utilize a pharmacological approach involving infusions of the sympathomimetic agent isoproterenol to repeatedly trigger cardiorespiratory sensations and anxiety during meal anticipation, to facilitate the development of tolerance or a reduction of the anxiety/fear response in individuals with anorexia nervosa. The investigators aim to conduct a proof of principle study to assess for evidence of initial efficacy of this new treatment approach. As a comparator condition, the researchers propose using repeated administration of saline infusions.
Timeline
- Start
- 2017-01
- Primary completion
- 2021-08
- Completion
- 2024-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isoproterenol | Small molecule | 0.1 ug | Intravenous |
| Subject | Isoproterenol | Small molecule | 4 ug | Intravenous |